XML 42 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Share-based compensation (Tables)
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The key assumptions utilized to calculate the grant-date fair values for these awards are summarized below:
Key Assumptions
Grant date share price
 
$
4.64

Expected term
 
1.0 - 1.3 years

Expected volatility
 
65
%
Dividend yield
 
%
Risk-free rate
 
2.61
%
Schedule of Share Options Activity
Key Assumptions
Grant date share price
 
$
4.64

Expected term
 
1.0 - 1.3 years

Expected volatility
 
65
%
Dividend yield
 
%
Risk-free rate
 
2.61
%

For the three months ended March 31, 2019, details of stock option activity were as follows:
Unvested Balance of Options
The unvested balance of options is shown below for the three months ended March 31, 2019:
 
 
Number of
options
 
Weighted average exercise price per share
 
Weighted average
remaining
contractual term
Unvested as of December 31, 2018
 

 
$

 

Granted
 
2,030,000

 
$
4.64

 
 
Unvested as of March 31, 2019
 
2,030,000

 
$
4.64

 
9.8 years

 
Schedule of Restricted Share Units, Common Stock Grants and Restricted Stock Activity
For the three months ended March 31, 2019, details of unvested RSU, common stock and restricted stock activity were as follows:
 
 
Number of units
 
Weighted average
grant-date fair value
Unvested as of December 31, 2018
 
3,831,965

 
$
7.95

Granted
 
1,725,930

 
$
4.78

Vested and delivered
 
(755,977
)
 
$
5.02

Withheld as treasury stock (1)
 
(321,631
)
 
$
5.25

Vested not delivered (2)
 
(673,338
)
 
$
7.25

Forfeited
 
(48,791
)
 
$
3.39

Unvested as of March 31, 2019
 
3,758,158

 
$
7.50

(1)
As discussed in Note 9, the increase in treasury stock was due to shares withheld to cover statutory withholding taxes upon the vesting of RSUs. As of March 31, 2019, there were 1,554,829 outstanding shares of treasury stock.
(2)
Vested not delivered represent vested RSUs or common stock grants with delivery deferred to a future time. For the three months ended March 31, 2019, there was a net increase of 673,338 shares included in vested not delivered, as a result of the vesting of RSUs with deferred delivery elections. As of March 31, 2019, there were 3,583,255 outstanding RSUs or shares of common stock grants included in vested not delivered.
Schedule of Share-based Compensation
For the three months ended March 31, 2019 and 2018, share-based compensation for the Company's stock option, RSU, common stock and restricted stock awards were allocated to the following accounts in the condensed consolidated financial statements:
 
 
Three Months Ended March 31,
(In thousands)
 
2019
 
2018
Sales and marketing
 
$
369

 
$
666

Product development
 
245

 
158

General and administrative
 
1,661

 
415

Spin-off transaction costs
 

 
5,409

Discontinued operations
 

 
15,713

Total share-based compensation expense
 
2,275

 
22,361

Capitalized in intangible assets of continuing operations
 
15

 
159

Capitalized in intangible assets of discontinued operations
 

 
181

Total share-based compensation
 
$
2,290

 
$
22,701